These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15330677)

  • 1. Strategies for managing breast cancer risk after the menopause.
    Warren R; Harvie M; Howell A
    Treat Endocrinol; 2004; 3(5):289-307. PubMed ID: 15330677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of breast cancer: implications for postmenopausal women.
    Fabian CJ; Kimler BF
    Drugs Aging; 2002; 19(1):43-78. PubMed ID: 11929326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of risk of breast carcinoma in postmenopausal women.
    Biglia N; Defabiani E; Ponzone R; Mariani L; Marenco D; Sismondi P
    Endocr Relat Cancer; 2004 Mar; 11(1):69-83. PubMed ID: 15027886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
    Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
    Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
    J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy in women with a history of breast cancer.
    Seifert M; Galid A; Kubista E
    Maturitas; 1999 Jun; 32(2):63-8. PubMed ID: 10465373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of breast cancer.
    Olver IN
    Med J Aust; 2016 Nov; 205(10):475-479. PubMed ID: 27852187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis approach to a-symptomatic post-menopausal women: breast cancer.
    Aguas F; Martins A; Gomes TP; de Sousa M; Silva DP;
    Maturitas; 2005 Nov; 52 Suppl 1():S23-31. PubMed ID: 16126355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of breast cancer in the older patient.
    Minton SE
    Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-reducing strategies for breast cancer--a review of recent literature.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(6):274-7. PubMed ID: 15646397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.
    Armstrong K; Chen TM; Albert D; Randall TC; Schwartz JS
    Obstet Gynecol; 2001 Dec; 98(6):996-1003. PubMed ID: 11755544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
    Bevers TB
    J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
    Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
    Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can breast cancer be prevented?].
    Vatten LJ
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case-control study in the Region of Western Pomerania (Poland).
    Kruk J
    Asian Pac J Cancer Prev; 2007; 8(4):513-24. PubMed ID: 18260721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.